Insider Profile
Manning, Anna
1
Companies Filed At
1
Open-Market Buys (2yr)
$116K
Buy Value (2yr, open-market)
Jun 30, 2026
Most Recent Trade
14
Credibility
Score
62%
Hit Rate
+4.1%
Avg 90d Return
+2.6%
Median 90d Return
8
Evaluated Trades
+16.9%
Best Trade
-6.0%
Worst Trade
Hit rate and returns are based on 8 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
—
Hit Rate · 90d
-14.1%
Median Alpha · 90d
1
Closed Buys Evaluated
0%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 1 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Jun 30, 2026 $MFC
Manulife Financial
— Other Buy 1,472 — — 34
Jun 30, 2026 $MFC
Manulife Financial
— Plan / DRIP Buy 104 — — 34
Mar 31, 2026 $MFC
Manulife Financial
— Other Buy 1,782 — — 34
Mar 31, 2026 $MFC
Manulife Financial
— Plan / DRIP Buy 108 — — 34
Dec 31, 2025 $MFC
Manulife Financial
— Plan / DRIP Buy 77 — — 34
Dec 31, 2025 $MFC
Manulife Financial
— Other Buy 1,572 — — 34
Sep 30, 2025 $MFC
Manulife Financial
— Other Buy 1,857 — — 34
Sep 30, 2025 $MFC
Manulife Financial
— Plan / DRIP Buy 69 — — 34
May 13, 2025 $MFC
Manulife Financial
— Open Market Buy 2,615 $44.40 $116K 34
Mar 31, 2025 $MFC
Manulife Financial
— Other Buy 1,867 — — 34
Mar 31, 2025 $MFC
Manulife Financial
— Plan / DRIP Buy 31 — — 34
Dec 31, 2024 $MFC
Manulife Financial
— Plan / DRIP Buy 11 — — 34
Dec 31, 2024 $MFC
Manulife Financial
— Other Buy 1,882 — — 34
Dec 31, 2024 $MFC
Manulife Financial
— Other Buy 1,168 — — 34
Aug 07, 2024 $MFC
Manulife Financial
— Other Sell — — — 34
Aug 07, 2024 $MFC
Manulife Financial
— Other Sell 7,715 — — 34
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.